DCF — MUSC HEALTH LANCASTER MEDICAL CENTER
Enterprise Value: $-210.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-210.5M
Enterprise Value
$-66.6M
PV of Cash Flows
$-143.9M
PV of Terminal Value
$-231.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $132.0M | $-13.1M | -10.0% | $-18.7M | $-17.0M |
| Year 2 | $136.0M | $-12.1M | -9.0% | $-17.9M | $-14.8M |
| Year 3 | $140.1M | $-11.1M | -8.0% | $-17.0M | $-12.8M |
| Year 4 | $144.3M | $-10.7M | -7.0% | $-16.8M | $-11.5M |
| Year 5 | $148.6M | $-10.7M | -7.0% | $-17.0M | $-10.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-210.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$128.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10428562203047026
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5